Novo Nordisk News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

16.12.24	Novo Nordisk To Invest DKK 8.5 Bln For New Production Facility In Denmark (RTTNews)
15.12.24	Catalent And Novo Holdings Complete All Regulatory Closing Conditions For Merger (RTTNews)
12.12.24	Novo Nordisk's Ozempic Gets CHMP's Positive Opinion To Include Kidney Disease Label Update (RTTNews)
11.12.24	Evotec And Novo Nordisk Launch Projects For LAB EN² Drug Discovery Accelerator (RTTNews)
21.11.24	MIT Scientists Develop Capsules To Directly Deliver Medicines To Gut (RTTNews)
06.11.24	Novo Nordisk 9-month Profit Rises - Quick Facts (RTTNews)
01.11.24	Novo Nordisk Reports Headline Results From Part 1 Of ESSENCE Trial With Semaglutide (RTTNews)
31.10.24	Semaglutide Reduces Obesity-Related Knee Osteoarthritis, Study Says (RTTNews)
21.10.24	Novo Nordisk: Oral Semaglutide Reduces Risk Of Cardiovascular Events In Phase 3 Trial (RTTNews)
18.10.24	Novo Nordisk: CHMP Recommends Approval Of Alhemo - Quick Facts (RTTNews)
25.09.24	Novo Nordisk CEO Faces Senate Questions Over High Prices Of Ozempic And Wegovy In US (RTTNews)
20.09.24	Novo Nordisk Slips On Phase 2a Clinical Trial Result With Monlunabant (RTTNews)
20.09.24	Novo Nordisk's Wegovy Recommended For Label Update To Reflect Heart Failure Benefits (RTTNews)
16.09.24	Korro Bio To Collaborate With Novo Nordisk To Develop Two Therapeutic Candidates (RTTNews)
11.09.24	Novo's Saxenda Shows Promise For Younger Children With Obesity; Study (RTTNews)
31.07.24	Study Says GLP-1 Drugs Could Help In Alzheimer's Disease Treatment (RTTNews)
11.07.24	FDA Issues Complete Response Letter For Novo Nordisk's Weekly Basal Insulin Icodec (RTTNews)
26.06.24	Novo Nordisk Discontinues Ocedurenone Trial, To Record Impairment Loss (RTTNews)
25.06.24	Novo Nordisk Plans $4.1 Bln NC Facility To Boost Obesity Drug Supply (RTTNews)
24.06.24	Study Says Wegovy Induces Higher Weight Loss In Women Than Men (RTTNews)
24.06.24	Novo Nordisk Reports Superiority Of Mim8 Prophylaxis In Hemophilia A Trial (RTTNews)
17.06.24	Novo Nordisk CEO Agrees To Testify In US Senate Hearing Over Ozempic, Wegovy Prices (RTTNews)
24.05.24	Study Says Novo Nordisk's Ozempic Reduces Kidney Disease Risks (RTTNews)
16.05.24	Novo Nordisk Building Site Hit By Fire (RTTNews)
02.05.24	Novo Nordisk Q1 Net Profit Rises (RTTNews)
30.04.24	Biotech Stocks Facing FDA Decision In May 2024 (RTTNews)
10.04.24	Ginkgo Bioworks Announces Expansion Of Partnership With Novo Nordisk - Quick Facts (RTTNews)
22.03.24	US Medicare To Cover Wegovy For Patients With Cardiovascular Disease (RTTNews)
21.03.24	Novo Nordisk Declares Dividend At Annual General Meeting (RTTNews)
09.03.24	FDA Approves Expanded Indication For Novo Nordisk's Wegovy To Reduce Cardiovascular Risk (RTTNews)
05.03.24	Paratek Reports Positive Data For Nuzyra As Post-exposure Prophylaxis Of Pulmonary Anthrax In NHPs (RTTNews)
05.03.24	Novo Nordisk Says FLOW Trial Achieves Primary Endpoint (RTTNews)
05.02.24	Novo Nordisk To Acquire Three Catalent Manufacturing Sites From Novo Holdings (RTTNews)
05.02.24	Novo Holdings To Acquire Catalent (RTTNews)
31.01.24	Novo Nordisk FY23 Profit Rises; Sales Up 36% At CER (RTTNews)
08.01.24	Novo Nordisk's COMBINE3 Phase 3 Trial Reveals Positive Results For Once-weekly IcoSema In Diabetes (RTTNews)
04.01.24	Novo Nordisk Enters Collaboration Agreements With Omega And Cellarity (RTTNews)
14.12.23	Alkermes To Sell Development And Manufacturing Facility In Athlone - Quick Facts (RTTNews)
16.10.23	Novo Nordisk To Buy Hypertension Drug Ocedurenone From KBP Biosciences For Up To $1.3 Bln (RTTNews)
13.10.23	Novo Nordisk Raises FY Sales, Operating Profit Outlook - Quick Facts (RTTNews)
11.10.23	Novo Nordisk To Stop Ozempic Kidney Trial On Meeting Certain Pre-specified Criteria; Stock Up (RTTNews)
26.09.23	Evotec, Novo Nordisk Roll Out LAB EN To Accelerate Translation In Cardiometabolic Diseases (RTTNews)
25.09.23	Novo Nordisk To Leverage Valo's Opal Computational Platform; Licenses Drug Discovery Programmes (RTTNews)
01.09.23	Novo Nordisk Surpasses LVMH To Claim Europe's Most Valuable Company Title (RTTNews)
25.08.23	Novo Nordisk's Wegovy Proves Superior To Placebo In People With HFpEF And Obesity (RTTNews)
10.08.23	Novo Nordisk H1 Net Profit Rises, Sales Up 29%; Increases Full Year Outlook (RTTNews)
26.06.23	Zealand Pharma Submits Marketing Authorization Application To EMA For Dasiglucagon (RTTNews)
05.06.23	Novo Nordisk In Talks To Acquire Controlling Stake In BIOCORP (RTTNews)
13.04.23	Novo Nordisk Q1 Sales Up 25% At CER; Raises FY Outlook (RTTNews)
12.04.23	Nordisk In Deal With Aspect To Develop Treatment For Diabetes And Obesity (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	76.62	0.39 %	K V
Part Grp Hldg	1’271.50	0.36 %	K V
Holcim	89.08	0.25 %	K V
Logitech Intl	74.82	-0.05 %	K V
Lonza Grp	540.60	-0.15 %	K V
UBS Group	27.82	-1.24 %	K V
Sika	223.10	-1.37 %	K V
Nestle	74.10	-1.49 %	K V
Swiss Re	129.60	-1.78 %	K V
Givaudan	3’961.00	-2.46 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Novo Nordisk (spons. ADRs)

Aktien Top/Flop

Novo Nordisk Peer Group Nachrichten

Meistgelesene Nachrichten